HK Stock MarketDetailed Quotes

01672 ASCLETIS-B

Watchlist
  • 3.240
  • +0.230+7.64%
Market Closed Jan 2 16:08 CST
3.15BMarket Cap-11.10P/E (TTM)

ASCLETIS-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ASCLETIS-B Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 0.000--
Aug 30, 20242024/H10.000 / 0.000--
Mar 25, 20242023/H210.090M / 20.700M--
Aug 21, 20232023/H146.506M / 46.500M--
Mar 20, 20232022/H215.872M / 42.399M--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 0.000--
Aug 30, 20242024/H10.000 / 0.000--
Mar 25, 20242023/H210.090M / 20.700M--
Aug 21, 20232023/H146.506M / 46.500M--
Mar 20, 20232022/H215.872M / 42.399M--

Unlock Free Earnings Estimates

ASCLETIS-B Earnings Reports

  • ASCLETIS-B: Interim Report 2024

    Sep 27, 2024 05:00 ET

  • ASCLETIS-B: INTERIM RESULTS ANNOUNCEMENTFOR THE SIX MONTHS ENDED JUNE 30, 2024ANDSUPPLEMENTAL ANNOUNCEMENT IN RELATIONTO 2023 ANNUAL REPORT

    Aug 30, 2024 05:00 ET

  • ASCLETIS-B: PROFIT WARNING

    Aug 7, 2024 09:21 ET

  • ASCLETIS-B: NOTICE OF BOARD MEETING

    Jul 30, 2024 05:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Buy

    • Strong Buy

      33.33%

    • Buy

      66.67%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Pharmaceutical Companies
    Pharmaceutical Companies
    Intraday-0.20%